Results 281 to 290 of about 1,440,335 (353)

In silico drug sensitivity predicts subgroup-specific therapeutics in medulloblastoma patients. [PDF]

Sci Rep
Jermakowicz AM, Ruiz L, Chu J, Jangde N, Suter RK, Kadan-Lottick NS, Hanson D, Ayad NG.   +7 more
europepmc   +1 more source

Trends in Dermatopolymyositis Mortality, 1999–2022: A Nationwide Population‐Based Study, United States

Arthritis Care &Research, EarlyView.
We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley   +1 more source

Old Drugs, New Battles: Unleashing Repurposed Drug Classes in Triple-Negative Breast Cancer Treatment. [PDF]

Int J Mol Sci
Tshimweneka VS, Mhlanga TV.
europepmc   +1 more source

Reduction in Renal Relapse and Preservation of Long‐Term Kidney Function After Lupus Low Disease Activity in Patients With Lupus Nephritis

Arthritis Care &Research, EarlyView.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE), but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung, Desmond Y. H. Yap, Ka Lai Lee, Philip H. Li, Iris Y. K. Tang, Chak Sing Lau, Shirley C. W. Chan   +6 more
wiley   +1 more source

Clinical application and drug resistance mechanism of gemcitabine. [PDF]

Front Cell Dev Biol
Zhang X, Qi B, Chen J.
europepmc   +1 more source

The impact of recent approvals on future alzheimer's disease clinical development: Statistical considerations for combination trials. [PDF]

J Prev Alzheimers Dis
Dickson SP, Mallinckrodt C, Burstein AH, Nisenbaum L, Fillit HM, Zhang C, Hendrix SB.   +6 more
europepmc   +1 more source

Drug resistance in cancer: molecular mechanisms and emerging treatment strategies. [PDF]

Mol Biomed
Li J, Hu J, Yang Y, Zhang H, Liu Y, Fang Y, Qu L, Lin A, Luo P, Jiang A, Wang L.   +10 more
europepmc   +1 more source

Network Medicine-Based Approach Reveals Cyclosporine and Selinexor Drug Combination as an Effective Therapy against SARS-COV-2

AKM Azad
openalex   +2 more sources

The role for artificial intelligence in identifying combination therapies for Alzheimer's disease. [PDF]

J Prev Alzheimers Dis
Cheng F, Sha Z, Zhou Y, Hou Y, Zhang P, Pieper AA, Cummings J.   +6 more
europepmc   +1 more source

Breast Cancer Treatments: Drugs Targeting the PI3K/AKT/mTOR Pathway, TNBC Therapy and Future Directions: A Review. [PDF]

Life (Basel)
Dynarowicz K, Bartusik-Aebisher D, Koszarska K, Kotlińska A, Aebisher D.   +4 more
europepmc   +1 more source